New Resource:

in , ,

As an organization founded by family members of those with type 1 diabetes (T1D), JDRF has made insulin access a top priority. JDRF believes that insulin should be available at a reasonable, predictable out-of-pocket cost. Affordable insulin helps people with T1D avoid costly emergency room visits, inpatient admissions, and other complications and saves lives. While some progress has been made, there is more to be done, and JDRF will not rest until we have long-term solutions that make life-saving insulin affordable for everyone, whether someone has private insurance, Medicare, or no insurance at all.

Through our Coverage2Control campaign, we’ve rallied our community to call for insulin manufacturers, health plans, employers, and the government to take action to lower the cost of insulin. JDRF executives have met repeatedly with the leadership of each of the three major insulin manufacturers and called on them to lower costs for insulin. JDRF’s President & CEO, Aaron J. Kowalski, Ph.D., has testified before Congress, and met with senior Administration officials. JDRF advocates from across the country have met with hundreds of Members of Congress and more than 50,000 people have petitioned their health plans.

Recently, a new resource for accessing affordable insulin was launched by our partners at Beyond Type 1. connects people with diabetes in the United States to the insulin access and affordability options that match their unique circumstances. is an important tool for people who need help affording their insulin today, regardless of the brand of medication. On, users answer a few questions (such as location, insurance type, income, and prescription) then receive customized action plans to guide them to solutions that best serve their unique circumstances.

Beyond Type 1 advocates for high quality, modern insulin to be available to people with diabetes regardless of employment or insurance status, across all demographics, without barriers, and at an affordable and predictable price point. Until that is achieved, is a tool for those needing access to insulin options immediately. is a program of Beyond Type 1. The program is supported by a coalition of partners helping connect those in need to lower-cost insulin now, including the American Diabetes Association (ADA), the Association of Diabetes Care and Education Specialists (ADCES), the Endocrine Society, Feeding America, JDRF, The Leona M. and Harry B. Helmsley Charitable Trust, the National Association for the Advancement of Colored People (NAACP), and the National Hispanic Medical Association (NHMA). is funded by Lilly, Mylan, Novo Nordisk, and Sanofi.

If you or someone you love needs help accessing insulin, go to This resource will create a custom action plan with options specific to your circumstances. For support using or feedback on any access/assistance programs, please reach out to: